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remodeling after endovascular treatment for
complicated ulcer-like projection in patients with
type B aortic intramural hematoma
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Ichiro Sakamoto, MD,a and Masataka Uetani, MD,a Nagasaki, Japan
Objective: The purpose was to investigate changes of the affected aorta after endovascular treatment for complicated ulcer-
like projection (ULP), including aneurysmal change or rupture of ULP, or both, in patients with type B aortic intramural
hematoma (IMH).
Methods: The study evaluated 18 patients (nine men) undergoing thoracic endovascular aortic repair for progressive
aneurysmal formation of ULP (n[ 17), rupture of ULP (n[ 5), or both. Patients were a median age of 72 years (range,
45-83 years). Regular follow-up computed tomography studies were performed after treatment (mean follow-up,
61.2 months). A workstation was used to calculate changes on computed tomography images in the size or volume of
ULP, affected aorta, and IMH. The growth rate of the volume of the affected aorta and IMH was also calculated before
and after treatment. We evaluated the data using the paired t-test.
Results: A stent graft was successfully deployed and ULPs disappeared in all patients. IMH disappeared in 16 or decreased
in two after treatment. There were signiﬁcant differences in the mean maximum aortic diameter (37.8 6 5.2 vs 34.5 6
5.2 mm; P[ .0006), mean IMH volume (39.4 6 12.1 vs 2.0 6 6.0 mL; P < .0001), and total volume of the aorta with
IMH (158.1 6 40.2 vs 128.9 6 28.0 mL; P < .0001) before and after treatment.
Conclusions: Endovascular treatment is a useful treatment for complicated ULP in patients with IMH. Endovascular
treatment also contributes to ideal remodeling of the affected aorta. (J Vasc Surg 2014;59:693-9.)Aortic intramural hematoma (IMH), one of the vari-
ants of aortic dissection (AD), has been considered as an
important disease entity in the differential diagnosis of
acute aortic syndrome.1,2 Although diagnostic criteria of
IMH have been established based on various imaging
modalities,3-5 their pathophysiologic link has not fully
established.6-10 In patients with IMH, ulcer-like projection
(ULP), noted as a focal contrast enhancement in the
thrombosed false lumen on computed tomography (CT),
has been described.4,11,12
Recently, endovascular treatment in patients with ULP
to prevent progression to double-barreled AD, aneurysm,
or rupture, has been reported; however, no information
is available about the outcomes of these patients after
endovascular treatment. Endovascular treatment markedly
improved IMH in several reports, but only a few patients
were reported.13 In addition, clinical implications of endo-
vascular treatment for ULP have not been understood. Thethe Departments of Radiologya and Cardiovascular Surgery,b Naga-
ki University School of Biomedical Sciences.
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://dx.doi.org/10.1016/j.jvs.2013.08.100purpose of this study was to investigate changes of the
affected aorta after endovascular treatment of complicated
ULP, including aneurysmal change or rupture of ULP, in
patients with IMH.
METHODS
This retrospective study was approved by the Nagasaki
University School of Biomedical Sciences Institutional
Review Board, which waived the informed consent
requirement.
Study population. Between January 2004 and March
2012, 70 consecutive patients were admitted to our
hospital with a diagnosis of acute type B IMH (not
involving the ascending aorta). All 70 patients had chest
pain or sudden back pain, and CT assessments were ob-
tained #24 hours from symptom onset. IMH was deﬁned
on the CT image as crescent or circular hematoma in the
aortic wall without direct ﬂow communication from the
true lumen, except for ULP. The CT studies were used
to detect the presence of ULP, deﬁned as a little
contrast-enhanced island-like lesion within the IMH with
direct communication from the true lumen or a localized
blood-ﬁlled lesion protruding into the IMH. Precontrast
and postcontrast CT images were used to differentiate
ULP from penetrating atherosclerotic ulcer and to distin-
guish it from intimal calciﬁcation.1
The 70 patients were admitted, and intravenous anti-
hypertensive drugs were used to control systolic blood
pressure between 100 and 120 mm Hg. After stabilization,693
Table I. Patient characteristics, clinical proﬁle,
computed tomography (CT) examination, and outcome
in 18 patients
Parameter
No. (%) or
median (range)
Male-to-female ratio 9:9
Age, years
Total 72 (45-86)
Men 66 (70-86)
Women 79 (43-82)
Hypertension 16 (90)
Diabetes 5 (28)
Renal failure 3 (17)
Current smokers 8 (50)
CT scans per patient 5 (3-10)
CT follow-up after endovascular
treatment, months
61.2 (0.3-131)
Stent graft
Homemade 6 (33)
Gore TAGa 10 (56)
Zenith Tx2b 2 (11)
Complication due to endovascular treatment 2 (11)
Deathsc 3 (17)
aW.L. Gore and Associates, Flagstff, Ariz.
bCook, Bloomington, Ind.
cAll deaths occurred after endovascular treatment.
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systolic blood pressure at <120 mm Hg. Patients without
complications, such as progression of IMH, ULP, double-
barreled AD, and rupture, were discharged #1 month
from the onset. The patients were monitored regularly after
discharge. A regular follow-up CT study was performed
#2 weeks and 2 months after discharge, followed by
a CT study every 6 months to 1 year.
ULPs were seen during the follow-up period in 31 of
70 patients (44%) with type B IMH. Initially, medical
treatment was performed for all 70 patients.
In two patients, ULP progressed to type A double-
barreled AD. ULP in two patients progressed to aneurysm,
but open surgery was selected because the ULP was iden-
tiﬁed in the proximal aortic arch. In one patient, ULP
progressed to type B double-barreled AD, but medical
treatment was selected because it was stable. The ULP in
eight patients disappeared or was stable during the
follow-up period. Finally, 18 patients (9 women and 9
men) with thoracic endovascular aortic repair were evalu-
ated (Table I). They were aged between 45 and 83 years
(median, 72 years; interquartile range, 53-70 years).
Our thoracic endovascular program was initiated in
1999 with the ﬁrst intervention performed for AD;
however, until 2008, when the ﬁrst stent graft was
commercially available, endovascular treatment was gener-
ally reserved for patients considered poor candidates for
open repair. Since that time, endovascular treatment has
been the option of choice for complicated ULP in patients
with type B IMH if anatomically suitable, with open
surgery reserved for nonendovascular treatment candidates.
This study deﬁned complicated ULP as (1) progressive
aneurysmal dilatation (size of the aorta with ULP >1.5
times normal) or (2) rupture of the ULP, or both. We
considered these ﬁndings as indications for intervention.
Endovascular treatment was evaluated in a multidisciplinary
fashion with the involvement of thoracic surgeons and
interventional radiologists.
Endoluminal exclusion of ULP. All 18 patients
underwent endovascular treatment through a femoral
artery. Devices used included a homemade stent graft in
six, TAG (W. L. Gore and Associates, Flagstaff, Ariz) in
10, and Zenith TX2 (Cook Medical, Bloomington, Ind)
in two. The proximal site for the Zenith TX2 was in the
healthy aortic wall. The homemade stent grafts were
constructed of self-expanding stainless steel Gianturco
Z-stents (Cook Medical) covered with ultrathin woven
polyester (Dacron; DuPont, Wilmington, Del) graft
material (thickness, 0.1 mm; porosity, 150 mL/cm2/
min/120 mm Hg; Ube Industries, Ube, Japan).
All procedures were performed in a unit with ﬂuoro-
scopic and angiographic guidance. We did not use intravas-
cular ultrasound or transesophageal echocardiography.
General anesthesia with tracheal intubation was adminis-
tered to all patients. An 8F sheath was inserted into the
left femoral artery, and a 5F calibrated angiographic pigtail
catheter was advanced into the ascending aorta to perform
arteriography and permit arteriographic evaluation of thedistance between the left subclavian artery and ULP. Arte-
riotomy was performed on the femoral artery originating
from the true lumen. A 5F pigtail catheter and a 0.035-
inch guidewire were advanced into the true lumen through
this arteriotomy site until the ascending aorta was reached.
A Lunderquist Extra Stiff Wire Guide (Cook Medical Inc)
was advanced into the ascending aorta using the catheter
exchange technique. After digital subtraction angiography
was performed to conﬁrm that the catheter was in the
true lumen, the relative data of the aortic lesion were
measured again, and the position of the proximal landing
zone was marked on the screen. After intravenous admin-
istration of heparin sodium (0.5 mg/kg), the stent graft
delivery system was advanced over the Lunderquist Extra
Stiff Wire Guide under ﬂuoroscopy and placed within the
true lumen. When the proper position was reached, the
systolic pressure was decreased to <80 to 90 mm Hg to
ensure precise stent graft positioning. The stent graft was
deployed by pulling back the sheath with the mandrel
pusher ﬁrmly ﬁxed.
The ULP was covered with the stent graft. The left
subclavian artery or left common carotid artery, or both,
were covered for adequate coverage of the ULP. We did
not cover all sites of IMH. Each patient was treated with
one endograft prosthesis. The left subclavian artery was
intentionally occluded in two patients after an occlusion
test of this artery showed collateral circulation to the left
upper limb from the left vertebral artery. Both left subcla-
vian and left common carotid arteries were intentionally
occluded in one patient after right subclavian-to-left
common carotid artery bypass was performed.
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ment to conﬁrm coverage of ULP and blood ﬂow of the
aortic lumen and branch vessels. After removal of the large
sheath, the arteriotomy was repaired.
Analysis of CT and clinical data. CT was performed
using Somatom Sensation 16 (Siemens Medical Solutions,
Forchheim, Germany) or Somatom Deﬁnition (Siemens
Medical Solutions). All axial CT images were obtained in
a contiguous 1- to 5-mm-thick section. Unenhanced and
enhanced images were obtained from the thoracic inlet to
the inguinal level in the craniocaudal direction. Coronal,
oblique coronal, and sagittal reformatted images were also
obtained. An automated injector was used to administer
100-mL iomeprol contrast material (Iomeron300; Bracco,
Milan, Italy) intravenously at a rate of 3 mL/s, followed by
a saline chaser.
Three-dimensional reconstruction software, Aquarius
iNtuition 4.4 (TeraRecon, San Mateo, Calif), was used to
measure the IMH and aorta with IMH volumetrically.
On three-dimensional images reconstructed from CT
Digital Imaging and Communications in Medicine
(DICOM) data, the free region-of-interest tool was applied
to deﬁne the aorta and IMH. With slice-by-slice deﬁnition,
the software generated volume information about the
selected vessel semiautomatically.
The aortic arch was deﬁned as the segment between
the brachiocephalic artery and the estimated ligamentum
arteriosus. The descending aorta was deﬁned as the
segment between the estimated ligamentum arteriosus
and the aortic hiatus of the diaphragm.
CT images were evaluated by two experienced cardio-
vascular radiologists (E.S., I.S.), each with >10 years of
experience. Final decisions regarding the ﬁndings were
reached by consensus.
Data retrospectively obtained by reviewing the medical
records included patient symptoms and signs, CT results,
therapeutic modality, course of treatment in the hospital,
and follow-up outcomes until the end of 2012. After endo-
vascular treatment, the mean CT follow-up period was
61.2 6 45.5 months (range, 0.3-131 months).
The CT measurements were used to calculate changes
in aortic size on multiplanar reconstruction images using
a workstation. The orientation of the multiplanar recon-
struction image was manipulated to obtain a plane parallel
to the aorta, and the largest short axial diameter of the
outer contour of the affected segment of aorta was
measured. Double-oblique cross-sectional sections perpen-
dicular to the long axis of the aortic lumen were used to
measure wall thickness using the workstation calipers,
expressed in millimeters. The maximal thickness of the
IMH was measured in the aortic arch, descending aorta,
and abdominal aorta after selecting the site with maximal
wall thickness by visual inspection.1 We measured the
transmural, circumferential, and longitudinal diameters of
each ULP and developed ULP. The transmural diameter
of the ULP was the maximal thickness of the ULP perpen-
dicular to the aortic wall, the circumferential diameter was
the maximal width of the ULP length parallel to thecurvature of the aortic wall, and the longitudinal diameter
was the maximal longitudinal cephalocaudal length of the
ULP.14 In all patients, the ﬁnal CT before endovascular
treatment was obtained #48 hours before the procedure.
The growth rate of the volume of the affected aorta
and IMH was calculated in the following manner: The
difference in the volume between (V1) and (V2) measure-
ments was divided by the time interval (T) between the two
measurements:
Growth rate of volume ¼ (V2 e V1)/T.
Finally, the growth rate per week before and after
endovascular treatment was calculated in the following
manner: The difference in the volume between the initial
(V10) and ﬁnal (V2 0) measurement before endovascular
treatment and the difference in the volume between the
ﬁnal (V2 0) measurement before endovascular treatment
and ﬁnal (V2”) measurement after endovascular treatment.
The time of ﬁnal (V2”) measurement after endovascular
treatment was when the IMH disappeared.
Growth rate of volume before endovascular
treatment ¼ (V2’ e V10)/1 week (7 days).
Growth rate of volume after endovascular treatment ¼
(V2” e V 02’)/1 week (7 days).
Statistical analysis. Continuous variables are expressed
as the mean6 standard deviation. Statistical analysis was per-
formed using clinical and morphologic variables with the
paired t-test and Mann-Whitney U test for continuous vari-
ables. In all tests, P < .05 was considered signiﬁcant. SPSS
11.5 software (SPSS, Chicago, Ill) was used for analysis.
RESULTS
In 18 patients, IMH was involved as follows: from the
aortic arch to abdominal aorta in 3, from the aortic arch to
descending aorta in 11, and descending aorta in 4. In six of
18 patients, ULPs were identiﬁed at initial CT. In 12
patients, ULPs appeared during the follow-up period
from 1 to 10 days after onset. Three of 18 ULPs were
located in the distal aortic arch, and 15 were in the
descending aorta.
Demographics and clinical factors of patients are re-
ported in Table I. Patients underwent endovascular treat-
ment from 7 to 91 days after onset. In 18 endovascular
treatments, 17 (94%) were performed for progressive
enlargement of ULP or in 5 (28%) for rupture, or both.
The stent graft was successfully deployed in all patients.
All ULPs were closed by the stent graft. No complications
occurred during procedures.
During the follow-up period, no patients had any
recurrence of ULPs after endovascular treatment. The
size of ULP was 20.1 6 6.4 mm before endovascular treat-
ment and 0.0 6 0.0 mm after treatment (Fig 1), with
a signiﬁcant difference (P < .0001).
In two of 18 patients (11%), additional aortic injury
occurred during the follow-up period, which was diag-
nosed by CT. One patient had retrograde AD 2 years after
endovascular treatment. This patient had no symptoms
and refused surgery. One patient had pseudoaneurysm
formation 6 months after endovascular treatment (Fig 2).
Fig 1. An 81-year-old woman with type B acute intramural hematoma (IMH) of the aorta. A, At onset, contrast-
enhanced computed tomography (CT) images show the ulcer-like projection (ULP) in the descending aorta
(arrow). B, A contrast-enhanced CT image 2 months after onset shows an enlarged ULP in the descending aorta
(arrow). C and D, Contrast-enhanced CT images 2 weeks after endovascular treatment show that the ULP has dis-
appeared. IHM has also decreased in size. E, A nonenhanced CT image 1 year after endovascular treatment shows that
the IHM has disappeared.
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vascular treatment. No other complications due to endo-
vascular treatment occurred during the follow-up period.
No patients had a perioperative stroke or permanent para-
plegia. No endoleaks or ULP occurred.
Three patients (17%) died during the follow-up period,
one patient each of pneumonia, abdominal aortic rupture,
and cerebral infarction at 10, 45, and 823 days from onset,respectively. Although the causes of death were not related
to the endovascular treatment, one patient was classiﬁed as
a perioperative death.
Changes of the aorta with IMH before and after
endovascular treatment
Before endovascular treatment. In all patients, IMH
was persistent before endovascular treatment. A comparison
Fig 2. An 83-year-old woman with type B acute intramural hematoma (IMH) of the aorta. A, A contrast-enhanced
computed tomography (CT) image 3 months after onset shows progressive ulcer-like projection (ULP) in the
descending aorta (arrow). B, She had severe chest pain 1 year after endovascular treatment. A contrast-enhanced CT
image shows that ULP had disappeared; however, mediastinal hematoma is seen (arrow). C, Contrast-enhanced CT
images show a pseudoaneurysm caused by the edge of the stent graft in the aortic arch (arrow). D, CT angiography
shows pseudoaneurysm caused by the edge of the stent graft in the aortic arch (arrow).
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showed the maximum thickness of false lumen IMH
in four patients (22%) increased between initial and ﬁnal
CT before endovascular treatment. The mean maximum
thickness of the false lumen at the initial and ﬁnal
CT before endovascular treatment was 8.9 6 4.2 and
10.8 6 4.3 mm, respectively, with no signiﬁcant difference
(P ¼ .0957). There were no signiﬁcant differences in the
mean maximum aortic diameter (37.9 6 6.8 vs 37.8 6
5.2 mm; P ¼ .944), mean IMH volume (42.5 6 13.1 vs
39.4 6 12.1 mL; P ¼ .844), and total volume of the aorta
with IMH (164.26 30.2 vs 158.16 40.2 mL; P ¼ .0755)
at the initial and ﬁnal CT before endovascular treatment
(Fig 1; Table II).
After endovascular treatment. A comparison of ﬁnal
CTs before and after endovascular treatment showed the
IMH disappeared from 60 to 90 days after endovascular
treatment in 16 patients (89%). In the remaining two
patients (11%), the maximum thickness and volume of
IMH decreased after endovascular treatment. The mean
maximum thickness of the false lumen at ﬁnal CTs before
and after endovascular treatment was 10.8 6 4.8 and0.9 6 2.4 mm, respectively, with a signiﬁcant difference
(P < .0001). There were also signiﬁcant differences in
the mean maximum aortic diameter (37.8 6 5.2 vs
34.5 6 5.2 mm; P ¼ .0006), mean IMH volume
(39.4 6 12.1 vs 2.0 6 6.0 mL; P < .0001), and total
volume of the aorta with IMH (158.1 6 40.2 vs
128.9 6 28.0 mL; P < .0001) at ﬁnal CTs before and after
endovascular treatment (Fig 1; Table II).
Growth rate of volume of false lumen and total aorta
before and after endovascular treatment
The growth rates of the mean false lumen volume
before and after endovascular treatment were 3.3 6 4.1
and 7.4 6 5.7 mL/wk, respectively, with a signiﬁcant
difference between (P ¼ .0178). There were no signiﬁcant
differences in the growth rates of total volume of the aorta
with IMH (4.06 4.8 vs 5.46 4.6 mL/wk; P ¼ .5513)
before and after endovascular treatment.
DISCUSSION
Current indications for endovascular treatment of
type B IMH generally cover patients who have disease
Table II. Aortic remodeling parameters of computed tomography (CT) measurement before and after endovascular
treatment (ET)
Variable
Initial CT before ET,
Pa
Final CT after ET,
Pb
Final CT,
mean 6 SD mean 6 SD mean 6 SD
IMH
Thickness, mm 8.9 6 4.2 .0957 10.8 6 4.3 <.0001 0.9 6 2.4
Volume, mL 42.5 6 13.1 .844 39.4 6 12.1 <.0001 2.0 6 6.0
Max aortic diameter with IMH, mm 37.9 6 6.8 .944 37.8 6 5.2 .0006 34.5 6 5.2
Total volume of affected aorta, mL 164.2 6 30.2 .0755 158.1 6 40.2 <.0001 128.9 6 28.0
IMH, Intramural hematoma; SD, standard deviation.
aFor comparison of data for initial CT data vs data for ﬁnal CT before ET.
bFor comparison of data for ﬁnal CT before ET vs data for ﬁnal CT after ET.
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(contained) rupture, persistent chest pain, or patients unre-
sponsive to antihypertensive treatment. Several studies
showed that endovascular treatment was performed for
penetrating atherosclerotic ulcer in patients with IHM,
but there are few reports in which endovascular treatment
was performed for complicated ULP in patients with IHM.
ULP is deﬁned as a localized contrast medium-ﬁlled
pouch in the hematoma of the false lumen, which obvi-
ously communicates with the true lumen.14-18 ULP has
been considered as a site of intimal disruption. These
lesions can develop to localized AD and aneurysmal dilata-
tion.1,14-19
In our study, all complicated ULPs were successfully
closed and disappeared after endovascular treatment, which
suggests that endovascular treatment can be a useful treat-
ment for complicated ULP. The proven safety and efﬁcacy
of endovascular treatment have led to its expanding appli-
cation to a wide variety of thoracic aortic pathologies20;
however, for complicated ULP, a generally accepted ther-
apeutic strategy has not been established, yet. Further
studies are therefore needed.
According to previous reports, IMH showed various
remodeling processes from complete resolution to compli-
cations such as development of aortic rupture, repeat
dissection, or aneurysmal dilatation.1,8,9,21,22 IMH may
be a more dynamic condition or more vulnerable than
double-barreled AD.8 Generally, initial medical treatment,
without surgical intervention, is selected for stable patients
with type B IMH.9,21 However, because of the variable
remodeling processes in patients with type B IMH, investi-
gations of long-term outcomes to determine prognostic
factors are needed.
In this study, IMH disappeared or decreased in size
after endovascular treatment in all patients. In addition,
there were signiﬁcant differences in the mean maximum
aortic diameter (37.8 6 5.2 vs 34.5 6 5.2 mm; P ¼
.0006) before and after endovascular treatment.
Previous reports have shown IMH can progress with
a signiﬁcantly lower long-term survival rate. The inci-
dence of IMH progression was 28.0%.9,23 A previous
report revealed a signiﬁcant association between ULP
and development of IMH,1 which suggests that ULPmay provide blood ﬂow or arterial pressure to the false
lumen.
Our results also revealed that closed ULP by endovas-
cular treatment was related to hematoma resorption of the
affected aorta. This supports that ULP may provide blood
ﬂow or arterial pressure to the false lumen. If endovascular
treatment closes the ULP, blood ﬂow or arterial pressure of
the false lumen decreases or disappears. This mechanism
may contribute to ideal remodeling of the affected aorta.
A previous report showed that the appearance of an ULP
is predictive of progression (development of double-
barreled AD, increased hematoma thickness, or aortic
enlargement) in patients with type B IMH. This report
may support our speculation.10 In patients with pene-
trating atherosclerotic ulcers, we speculate that endovascu-
lar treatment may contribute to ideal remodeling of the
affected aorta by the same mechanism.
According to previous studies, aneurysmal dilatation is
seen in 53% of patients with IMH during the chronic
phase. This complication has also been reported previ-
ously,9,23 along with a progressive aneurysm development,
even with complete resolution.24 Because the aortic wall is
damaged by IMH, aneurysmal change can occur in the
affected aorta during the chronic phase.7 This study did
not show long-term results of the affected aorta treated
by endovascular repair. Further long-term studies are
needed to clarify the results of the affected aorta treated
by endovascular treatment.
Two of 18 patients presented with additional aortic
injury, but stent graft causation of these lesions was not
conﬁrmed. Recent reports showed that a stent graft-
induced new entry (SINE) tear developed preoperatively
or during follow-up in patients with double-barreled AD.
SINE was deﬁned as a new intimal tear damaged by the
stent graft itself, excluding those created by natural
disease progression or any iatrogenic injury.25,26 Proximal
and distal SINE represented SINE at the distal and prox-
imal ends of the endograft, respectively, with an incidence
of 3.2% and a mortality rate of 26.1%.25 Our study
showed that a stent graft-induced aortic injury may
occur in patients with IMH as a late complication.
We have to be aware of these complications after endo-
vascular treatment.
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patients was small, and the follow-up periods varied.
Further long-term studies involving larger numbers of
patients are needed.
Second, we used various types of stent grafts, which
may have a potential bias; however, no episodes based on
the type of stent graft were documented in this study.
CONCLUSIONS
This study revealed that endovascular treatment is
a useful treatment for complicated ULP in patients with
IMH. Endovascular treatment also contributes to ideal
remodeling of the affected aorta, because closure of ULP
may interrupt blood ﬂow or arterial pressure to the false
lumen; however, literature on the long-term efﬁcacy and
success of endovascular repair of IMH are still lacking.
Further long-term studies involving a larger sample are
needed.
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